About the Authors
- Marta Valenciano
-
* E-mail: m.valenciano@epiconcept.fr
Affiliation EpiConcept, Paris, France
- Esther Kissling
-
Affiliation EpiConcept, Paris, France
- Jean-Marie Cohen
-
Affiliation Réseau des GROG/Open Rome, Paris, France
- Beatrix Oroszi
-
Affiliation National Center for Epidemiology, Budapest, Hungary
- Anne-Sophie Barret
-
Affiliations Health Protection Surveillance Centre, Dublin, Ireland, European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, Stockholm, Sweden
- Caterina Rizzo
-
Affiliation National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Roma, Italy
- Baltazar Nunes
-
Affiliation Instituto Nacional de Saúde Dr Ricardo Jorge, Lisbon, Portugal
- Daniela Pitigoi
-
Affiliations Cantacuzino Institute, National Institute of Research – Development for Microbiology and Immunology, Bucharest, Romania, Universitatea de Medicina si Farmacie Carol Davila, Bucharest, Romania
- Amparro Larrauri Cámara
-
Affiliation National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain
- Anne Mosnier
-
Affiliation Réseau des GROG/Open Rome, Paris, France
- Judith K. Horvath
-
Affiliation National Center for Epidemiology, Budapest, Hungary
- Joan O'Donnell
-
Affiliation Health Protection Surveillance Centre, Dublin, Ireland
- Antonino Bella
-
Affiliation National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Roma, Italy
- Raquel Guiomar
-
Affiliation Instituto Nacional de Saúde Dr Ricardo Jorge, Lisbon, Portugal
- Emilia Lupulescu
-
Affiliation Cantacuzino Institute, National Institute of Research – Development for Microbiology and Immunology, Bucharest, Romania
- Camelia Savulescu
-
Affiliations EpiConcept, Paris, France, National Centre for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain
- Bruno C. Ciancio
-
Affiliation European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- Piotr Kramarz
-
Affiliation European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- Alain Moren
-
Affiliation EpiConcept, Paris, France
Competing Interests
J-M Cohen is a direct advisor for the French Minister of Health (MOH). His salary as Head of réseau des GROG is financed by the French MOH (76%) and Institut Pasteur (24%). The Institut Pasteur contribution is funded by a pool of five pharmaceutical firms (Roche, Glaxo SmithKline [GSK], Sanofi Pasteur, Solvay, Argène). As Head of Open Rome, he is involved in several epidemiological studies that are partially or fully funded by pharmaceutical companies (Sanofi-Pasteur, GSK, Roche), nonprofit organizations (Mutuelles, Résaeu DES France) or public institutions (ECDC, CU Strasbourg). He is a member of Association Mieux Prescrire and the advisory boards of Novartis, Roche, and Wyeth (free participation, no compensation). During the past five years, he has received travel grants from Sanofi-Pasteur and Roche. A. Mosnier is a member of the French MOH advisory board on influenza, and adviser for influenza to the French Health Insurance organization. As coordinator of the Réseau des GROG (French Influenza Sentinel network), her salary is funded by MOH (76%) and Institut Pasteur (24%). Institut Pasteur contribution is funded by a pool of five pharmaceutical firms (GSK, Roche, Sanofi-Pasteur, Solvay, Argène). She is involved, through the other institution with which she is affiliated and salaried (Open Rome research department), in the coordination or analysis of epidemiological studies partially or fully funded by Roche and GSK. She is member of the Groupe d'Expertise et d'Information sur la Grippe (GEIG) Scientific Board. During the last five years, she has received travel grants from Roche for speaking, or participation, at scientific meetings. All other authors have declared that no competing interests exist.
Author Contributions
ICMJE criteria for authorship read and met: M Valenciano, E Kissling, JM Cohen, B Oroszi, AS Barret, C Rizzo, B Nunes, D Pitigoi, AL Cámara, A Mosnier, JK Horvath, J O Donnell, A Bella, R Guiomar, E Lupulescu, C Savulescu, BC Ciancio, P Kramarz, A Moren. Agree with the manuscript s results and conclusions: M Valenciano, E Kissling, JM Cohen, B Oroszi, AS Barret, C Rizzo, B Nunes, D Pitigoi, AL Cámara, A Mosnier, JK Horvath, J O Donnell, A Bella, R Guiomar, E Lupulescu, C Savulescu, BC Ciancio, P Kramarz, A Moren. Designed the experiments/the study: M Valenciano, JM Cohen, C Rizzo, B Nunes, D Pitigoi, AL Cámara, A Mosnier, J O Donnell, R Guiomar, E Lupulescu, C Savulescu, BC Ciancio, P Kramarz, A Moren. Analyzed the data: E Kissling, JM Cohen, AS Barret, C Rizzo, D Pitigoi, A Moren. Collected data/did experiments for the study: JM Cohen, B Oroszi, AS Barret, C Rizzo, B Nunes, D Pitigoi, AL Cámara, A Mosnier, JK Horvath, J O Donnell, A Bella, R Guiomar, E Lupulescu, C Savulescu. Enrolled patients: JM Cohen, C Rizzo, D Pitigoi, A Mosnier, A Bella, E Lupulescu. Wrote the first draft of the paper: M Valenciano. Contributed to the writing of the paper: M Valenciano, E Kissling, JM Cohen, B Oroszi, AS Barret, B Nunes, D Pitigoi, AL Cámara, A Mosnier, JK Horvath, J O Donnell, R Guiomar, E Lupulescu, C Savulescu, BC Ciancio, P Kramarz, A Moren. Coordinated the study at the national level: B Oroszi, C Rizzo, B Nunes, D Pitigoi, A Larrauri Cámara, J O'Donnell. Participated in protocol writing: M Valenciano, A Moren. Contributed to reviewing the data analysis: M Valenciano, A Moren. Wrote first draft and revised the overall manuscript with co-author inputs: M Valenciano. Participated in protocol writing: E Kissling. Adapted GROG network database to I-MOVE design: JM Cohen. Coordinated GROG Network during pandemic phase: JM Cohen. Coordinated the Sentinel network (réseau des GROG) in charge of patient enrollment: A Mosnier. Reviewed drafts of the article: J O'Donnell. Performed the laboratory diagnosis of the influenza virus infection: R Guiomar. Conceived the idea of a European network for monitoring influenza vaccine effectiveness: BC Ciancio.